A human interleukin 3 analog with increased biological and binding activities.
about
AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cellsA cytokine-cytokine interaction in the assembly of higher-order structure and activation of the interleukine-3:receptor complex.Binding in the growth hormone receptor complex.Identification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling.A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor.The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling.Saturation mutagenesis of human interleukin-3.Identification of functional domains of interleukin-3 by construction of primate interspecies chimera.Identification of key charged residues of human interleukin-5 in receptor binding and cellular activation.Homodimeric murine interleukin-3 agonists indicate that ligand dimerization is important for high-affinity receptor complex formation.Molecular modeling of the GM-CSF and IL-3 receptor complexes.Homology model of human interferon-alpha 8 and its receptor complex.A dual role for the N-terminal domain of the IL-3 receptor in cell signalling.Evidence for a lectin activity for human interleukin 3 and modeling of its carbohydrate recognition domain.Defining the Regions of Human Interleukin-5 Important in Receptor Binding and Cellular Activation
P2860
Q30637447-A3B16F06-7907-452F-B1EA-F7430EA10025Q33427864-9EC47092-8807-411D-930E-CD79AF5D9728Q33593803-729013E1-3C40-4991-B087-38DD98EF54D1Q34297178-554E8A19-C40A-494B-81D4-ACCE390D023DQ34304678-07031DC9-4FF4-48F5-AA6A-5841EAFE1E72Q34409307-9A57566E-9186-46A5-A387-EC712AD4C129Q34437425-B53BCCD8-D506-44D6-B462-1E81E6FF8882Q36681734-7403834B-9D02-4193-8F15-108374FDCFEAQ36716034-901598DF-FE4D-42C2-AA34-27BCE6A6CE02Q41333460-782DF696-6FE1-4E08-8999-BE11066AB8C1Q41498744-2F184280-6577-4A20-A89F-66E84259D3FFQ42844487-1D4E9A89-3327-4FDF-A521-9109B4101CE6Q42844691-3D9548C4-52FD-485E-9098-DAD1CE832161Q48158203-EC9F1ADE-CE50-4AE2-8966-22E2C1BF086DQ48562723-FC9111D2-8552-4345-86DA-FDDAC0146750Q57075429-EA1AD4FE-71CD-4B1C-95D5-C2F9AACEED74
P2860
A human interleukin 3 analog with increased biological and binding activities.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A human interleukin 3 analog with increased biological and binding activities.
@en
A human interleukin 3 analog with increased biological and binding activities.
@nl
type
label
A human interleukin 3 analog with increased biological and binding activities.
@en
A human interleukin 3 analog with increased biological and binding activities.
@nl
prefLabel
A human interleukin 3 analog with increased biological and binding activities.
@en
A human interleukin 3 analog with increased biological and binding activities.
@nl
P2093
P2860
P356
P1476
A human interleukin 3 analog with increased biological and binding activities.
@en
P2093
B Cambareri
J A Phillips
M F Shannon
P2860
P304
11842-11846
P356
10.1073/PNAS.89.24.11842
P407
P577
1992-12-01T00:00:00Z